RxDoctor Payments Data

Chitranjan Ranawat

New York, NYNPI 1326102724

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $14,926,637 of the $14,926,637 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Depuy Synthes Products, Inc..

$14,926,637in general payments, 2019–2025

Across 60 payments — averaging $248,777 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$14.9M

What the payments were for

  • Royalty or licence$14,926,637100%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Depuy Synthes Products, Inc.60$14,926,637

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →